Table 2 The correlation between the results of molecular tests and PE in patients with NSCLC

Age (per increase of ten years)

1.257 (0.519–1.595)(P = 0.020)

1.232 (0.661–1.822)(P = 0.100)

Sex (male as 1.0)

1.160 (0.487–1.673)(P = 0.098)

Smoking (non-smoker as 1.0)

1.396 (0.812–1.934)(P = 0.010)

1.518 (1.054–2.099)(P = 0.001)

D-dimer (per increase of 500 ng/ml)

1.779 (1.284–2.318) (P = 0.001)

1.762 (1.236–2.243) (P<0.001)

Concomitant DVT (no DVT as 1.0)

2.346 (1.832–2.818)(P<0.001)

2.859 (1.971–2.945)(P<0.001)

Positive molecular results (negative results as 1.0)

1.265 (0.914–1.537)(P = 0.025)

1.187 (0.674–1.532) (P = 0.176)

ALK(+)(negative results as 1.0)

1.576 (1.028–2.126)(P = 0.001)

1.685 (1.065–2.215)(P<0.001)

ROS1(+) (negative results as 1.0)

1.337 (0.878–1.990)((P = 0.030)

1.293 (0.921–2.006)((P = 0.125)

EGFR(+) (negative results as 1.0)

0.838 (0.596–1.157)((P = 0.025)

0.907 (0.614–1.289)((P = 0.352)

BRAF-V600E(+) (negative results as 1.0)

0.987 (0.774–1.811)(P = 0.032)

1.050 (0.567–1.935)(P = 0.212)

PD-L1(+)(negative results as 1.0)

1.437 (0.975–2.018)(P = 0.005)

1.798 (1.137–2.201)(P<0.001)

Platelet (per increase of 100 × 10⁹ /L)

1.654 (1.125–2.187)(P = 0.001)

1.731 (1.292–2.318) (P<0.001)